Peter B. Morgan, MD

Assistant Professor of Clinical Radiation Oncology, Academic Institute
Department of Radiation Oncology
Cancer Center
Houston Methodist The Woodlands Hospital
Houston Methodist
Weill Cornell Medical College

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Area Keywords

Imaging & Radiology
Cancer
Clinical Translation & Trials
Clinical Care

Fingerprint

Dive into the research topics where Peter B. Morgan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

8 Active

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Templeton, S., Arentz, C., Chang, J. C., Darcourt, J., Dubrovsky, E., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A. & Singh, M.
12/16/19 → …
Project: Clinical Trial
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Zhang, J., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Darcourt, J., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A., Randhawa, J. & Singh, M.
12/16/19 → …
Project: Clinical Trial
Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients
Zhang, J., Abdelrahim, M., Chang, J. C., Darcourt, J., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A., Shkedy, C. & Singh, M.
9/25/19 → …
Project: Clinical Trial
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer (NRG-GY006)
Zaid, T., Alaniz, A., Butler, E. B., Darcourt, J., Farach, A. M., Haque, W. M., Kamat, A. A., Morgan, P. B., Shadle, K. M., Shkedy, C., Singh, M. & Suri, A.
2/22/19 → …
Project: Clinical Trial
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With ? 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy
Niravath, P. A., Bernicker, E. H., Chang, J. C., Darcourt, J., Geyer, C. E., Heyne, K., Morgan, P. B. & Singh, M.
3/1/18 → …
Project: Clinical Trial

113 Citations
3 h-Index
4 Article

First Author Research Productivity of United States Radiation Oncology Residents: 2002-2007
Morgan, P. B., Sopka, D. M., Kathpal, M., Haynes, J. C., Lally, B. E. & Li, L., Aug 1 2009, In : International Journal of Radiation Oncology Biology Physics. 74, 5, p. 1567-1572 6 p.
Research output: Contribution to journal › Article
26 Scopus citations
WE‐D‐351‐09: Target Delineation, Reposition, and Dose Delivering Accuracies in CBCT‐Guided Stereotactic Radiotherapy of Small Lung Tumors
li, S., Kuritzky, N., Chan, P., Tsai, J., Zhang, X., Morgan, P., Micaily, B. & Miyamoto, C., Jun 2008, In : Medical Physics. 35, 6, 1 p.
Research output: Contribution to journal › Article
Radiation dose and late failures in prostate cancer
Morgan, P. B., Hanlon, A. L., Horwitz, E. M., Buyyounouski, M. K., Uzzo, R. G. & Pollack, A., Mar 15 2007, In : International Journal of Radiation Oncology Biology Physics. 67, 4, p. 1074-1081 8 p.
Research output: Contribution to journal › Article
49 Scopus citations
Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy
Morgan, P. B., Hanlon, A. L., Horwitz, E. M., Buyyounouski, M. K., Uzzo, R. G. & Pollack, A., Jul 1 2007, In : Cancer. 110, 1, p. 68-80 13 p.
Research output: Contribution to journal › Article

Open Access
38 Scopus citations